X. Zhang, Los Angeles, CA, United States of America
Cedars-Sinai Heart InstitutePoster Author Of 6 e-Posters
1131 - Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
Presentation Number
1131
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- N. Lam, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- D. Luthringer, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1132 - The Clinical Impact of Early vs Late HLA Donor-Specific Antibody Development After Heart Transplantation
Presentation Number
1132
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- J. Davis, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Hamilton, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1133 - Is the Luminex 1:8 Dilution Truly the Poor Man’s C1q for Patients Awaiting Heart Transplantation?
Presentation Number
1133
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1134 - Is First-year DSA After Heart Transplantation Truly a Biomarker for the Development of Cardiac Allograft Vasculopathy?
Presentation Number
1134
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- M. Curry, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Olive, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1136 - Novel Methods for Assessing Response to Desensitization
Presentation Number
1136
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Hamilton, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Norland, Los Angeles, CA, United States of America
- M. Pando, Temple, TX, United States of America
- J. Patel, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1137 - Pre-Transplant Memory/Antibody Status Predicts Rejection Risk in the First-Year After Heart Transplantation
Presentation Number
1137
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. MacKinnon, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America